Nucleus Wealth Insights

Join us in this week's podcast as Nucleus Wealth's Chief Investment Officer Damien Klassen, Senior Investment Analyst Radek Zeleny, and Head of Advice Samuel Kerr dive deep into the fast-growing market of weight loss drugs, exploring the latest trends, breakthroughs, and market dynamics. We provide an in-depth analysis of the top players in the industry, including established pharmaceutical giants and innovative startups that are shaking up the scene. Efficacy and safety of popular weight loss drugs, and what new treatments are on the horizon. Next, we pull out the crystal ball and consider what other sectors may be impacted and the likelihood of a significant investment theme emerging. ⁠View the presentation slides⁠⁠⁠⁠ To listen in podcast form click ⁠⁠⁠⁠here⁠⁠⁠⁠ Get an obligation-free ⁠⁠⁠⁠portfolio recommendation⁠⁠⁠⁠ to see how we would invest for you Learn more about the ⁠⁠⁠⁠hosts⁠⁠⁠⁠ Find us on social media: ⁠⁠⁠⁠Twitter⁠⁠⁠⁠ ⁠⁠⁠⁠Instagram⁠⁠⁠⁠ ⁠⁠⁠⁠Facebook⁠⁠⁠⁠ ⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠ Want to know more